IMMUCELL CORP /DE/ Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immucell Corp /De/ quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q2 2024.
  • Immucell Corp /De/ Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.5M, a 5.08% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.5M +$218K +5.08% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $4.55M +$2.37M +109% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.57M +$2.38M +108% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $4.22M +$2M +90.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.28M +$3.23M +308% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.18M +$1.1M +102% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.19M +$1.09M +97.9% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.22M +$1.08M +94.9% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $1.05M -$114K -9.76% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $1.08M -$115K -9.6% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 $1.11M -$111K -9.11% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1.14M -$110K -8.82% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.16M -$114K -8.93% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.19M -$113K -8.65% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.22M Dec 31, 2020 10-K 2022-03-30
Q3 2020 $1.25M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.28M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.31M Mar 31, 2020 10-Q 2020-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.